SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH - CEPHALON
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (16)10/31/2002 4:29:03 PM
From: Icebrg  Read Replies (1) of 109
 
RESEARCH ALERT- JP Morgan starts Cephalon as 'neutral'
Thursday October 31, 11:58 am ET

NEW YORK, Oct 31 (Reuters) - JP Morgan analyst Corey Davis started started the drugmaker Cephalon with a "neutral" rating on Thursday.

"We believe Cephalon, with 3 products on the market that are still very early in their life cycles, is a relatively low-risk story, with several years of 40% earnings growth to come," Davis said in a note to clients.

Comment: I wonder what their BUYs look like.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News